Genomic Alterations in Langerhans Cell Histiocytosis.

Abstract excerpt

The discovery of recurrent somatic genomic alterations in Langerhans cell histiocytosis (LCH) has led to a new understanding of LCH as a clonal neoplastic disorder. Most of the abnormalities described to date affect the RAS/RAF/MEK/extracellular-signal-regulated kinase (ERK) pathway: more than 50% of LCH cases carry activating mutations in BRAF, whereas another 10% to 28% carry activating mutations of MAP2K1,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to BRAF gene
• Share to Genetic Predisposition to Disease
• Share to Genetic Variation